CCTG

Today is #WorldHeadandNeckCancerDay and at #CCTG, we remain committed to advancing treatment options and improving outcomes for people affected by head and neck cancers. #HeadAndNeckCancer #SolvingCancerTogether #ClinicalTrials #CancerResearch

#CCTG Trials in Development quarterly update is now available. These are planned studies advancing cancer research across multiple disease sites. Keep an eye out for updates as new trials open for enrollment! #SolvingCancerTogether #CancerResearch buff.ly/6VDElKO

#CCTG’s BR38 trial has opened in Canada. The study is investigating if targeted radiotherapy added to ongoing immunotherapy can enhance treatment outcomes for metastatic non-small cell lung cancer. #LungCancer #SolvingCancerTogether buff.ly/B77E4vA

#CCTG’s SKC1 trial has opened in Canada. This study is evaluating whether adding immunotherapy to surgery can improve outcomes for individuals with advanced skin cancer. #SkinCancer #SolvingCancerTogether buff.ly/51M10Dh

Prioritizing #novel agents for #children with soft tissue #sarcoma - an effort to advance drug development & conduct of #clinical trials for this population sciencedirect.com/science/articl… @COGorg @C17Council @CCMB_Research @CDNCancerTrials

Thanks @tompowles1 @brian_rini @Uromigos for this wonderful podcast discussing structured exercise program benefits in resected CRC in the CHALLENGE trial! Love the fun discussion on running & how Chris Booth & team turned this idea into reality. Kudos to the study team on…

On #GlioblastomaAwarenessDay , #CCTG honors those affected by brain cancer and recognizes the ongoing need for research, innovation, and support in the fight against this aggressive form of #BrainCancer #SolvingCancerTogether

As we observe #BoneCancerAwarenessMonth, it is time to recognize the need for better treatments and support for those living with bone cancer through trials like SC29, exploring new ways to manage pain using targeted radiationTherapy. #CCTG Trial page - > buff.ly/DbQoPiH

July is #BoneCancerAwarenessMonth. At #CCTG, we’re committed to advancing clinical trials that help improve treatment options and outcomes for people living with rare bone cancers like sarcoma. #SarcomaAwarenessMonth #SolvingCancerTogether

We’re excited to welcome Lesley Beaton, the #CCTG #Gastrointestinal Patient Representative. Lesley brings a unique combination of scientific expertise and lived experience to her role, advocating for trials that are clear, accessible, and patient-informed. #PatientsAsPartners

As part of #SarcomaAwarenessMonth, #CCTG spotlights the SR7 study comparing the effects of receiving chemotherapy before surgery on patients and their #sarcoma compared to surgery alone. #SolvingCancerTogether Trial page -> buff.ly/40Nj60C

Today is #SarcomaAwarenessMonth , a reminder of the importance of continued research for this rare cancer. #CCTG remains committed to advancing clinical trials that help improve outcomes for #sarcoma patients. #SolvingCancerTogether

Join #CCTG in welcoming Catherine Caule, our new Patient Representative supporting the #Hematology Committee. As a long-time #lymphoma survivor and advocate, Catherine brings deep insight and compassion to the role. #SolvingCancerTogether #PatientsAsPartners

Happy Canada Day from all of us at #CCTG! We’re proud to contribute to groundbreaking research that unites Canadians in the fight against #cancer. #SolvingCancerTogether

Today is #InternationalPrideDay. Together, we stand for equality and inclusion in all aspects of life, including #cancercare and #research. #SolvingCancerTogether

#CCTG trial spotlight: The SC28 clinical trial is testing an app-based #mindfulness program to support #cancer survivors in managing stress, anxiety, and other post-treatment challenges. Trial page -> buff.ly/gB7RW4Q #NationalCancerWellnessAwarenessDay #NCWAD

On #NationalCancerWellnessAwarenessDay, we acknowledge the importance of comprehensive care for cancer patients. #CCTG is committed to advancing clinical research that enhances the quality of life for everyone living with #cancer. #NCWAD #SolvingCancerTogether

#TRIPLESWITCH Trial: Intensifying treatment for suboptimal PSA response in #mHSPC. @michael_ong, @sokolova_md & @TDorffOnc join @neerajaiims to discuss on UroToday. This joint CCTG-SWOG phase III trial addresses a critical gap by randomizing 830 patients with suboptimal PSA…

#CCTG trial spotlight: The SRC8 clinical trial is investigating whether adding #immunotherapy to #chemotherapy improves outcomes for people with metastatic or unresectable high-risk #sarcoma. #CancerImmunotherapyMonth #SolvingCancerTogether Trial page> buff.ly/D9zUCFO

Today, on #NationalIndigenousPeoplesDay, #CCTG recognizes the rich heritage, diverse cultures, and contributions of First Nations, Inuit, and Métis peoples while working towards equitable and culturally safe cancer research and care. #IndigenousPeoplesDay #SolvingCancerTogether